// App-Quantinova.ai

: FGFR3 mutation as a prognostic indicator in patients with urothelial carcinoma: A systematic review and meta-analysis.

Researchers

Presenter

  • Sidra Khalid

Principal Investigators

  • Bassam Mohammed Basulaiman

  • Jeff Emack

  • Christopher M. Booth

  • David Hernandez-Barajas

  • Ignacio Duran

  • Martin Smoragiewicz

  • Eitan Amir

  • Francisco Vera-Badillo

Medical Centers

  • Queen's University, Kingston, ON, CA

  • Hospital Universitario de Nuevo Leon, Monterrey, Mexico

  • Department of Radiology, H. Universitario Marques de Valdecilla, Santander, Spain

  • Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

Locations

  • Canada

  • Mexico

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • Fibroblast growth factor receptor 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved